NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept
In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial
DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects
Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume
House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI
NCI Audit Finds “Low Quality” Research At Calif. Foundation
DCE Board Approves Study of Breast Cancer On Long Island
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- CBER Director Vinay Prasad dared to “say no to drugs”
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC









